We generated 200 simulated data sets of 240 participants from this mechanism and analyzed each data set using longitudinal targeted minimum loss-based estimation (TMLE). This process was repeated across a range of values for ( 1 , 2 ). Results for our analysis are shown in Figure 1 . This figure shows power (thick black lines) as a function of ( 1 , 2 ). Because the analysis is not conducted on the odds ratio scale, we have also included grid lines (gray) for the corresponding risk differences. The vertical grid lines are labeled with the value of the difference in proportion of adherent participants (P3/P3+ versus control) at month three corresponding to the particular value of 1 . The horizontal grid lines are labeled with the value of the difference in proportion of adherent participants at month six. From the figure, we may conclude that the study has >80% power to detect a six-month treatment effect of 20% (difference in percentage adherence) even if there is no three-month effect, or conversely a three-month treatment effect of 20% even if there is no six-month effect. In the more realistic scenario, where there is a treatment effect at both time points, we have >80% power to detect effects if the three-and six-month treatment effects are >14%.
Though the baseline and interim participant characteristics were not predictive of adherence nor of censoring, we included these characteristics in the requisite regression models for TMLE. Thus, we expect that these power calculations will be conservative for the true power if participant characteristics are informative of adherence. 
